Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment
Journal of Visualized Experiments · 2026
DOI: 10.3791/70352 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Sydney Camfield und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, College of Medicine, University of Oklahoma. Hauptthemen laut MEDLINE: Disease Models, Animal, Inflammation, Neurodevelopmental Disorders. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Neurodevelopmental disorders (NDDs) arise from complex interactions between genetic and environmental risk factors, including prenatal immune activation. Maternal immune activation (MIA) in mice is a widely used model to study environmental contributions to NDDs; variability in experimental outcomes limits reproducibility. Here, we present a standardized protocol for inducing MIA during early gestation at embryonic day 9.5 (E9.5) in mice, incorporating multiple quality control metrics to assess immune response and predict pregnancy outcomes. Following administration of polyinosinic:polycytidylic acid (poly(I:C)), maternal serum cytokines are quantified to confirm robust immune activation, allowing an exclusion metric for low responders. Maternal weight trajectories from E0.5 to E12.5 are predictive of litter viability, with dams that produced litter exhibiting characteristic weight-gain patterns distinct from dams that lost a litter. We also observed that the animal vendor significantly influenced maternal immune response and litter viability, while poly(I:C) formulation was not a significant factor. Altogether, the protocol provides strategies to enhance the reproducibility of the early-gestational MIA model and the viability of the offspring by monitoring maternal immune response and weight changes, and by controlling animal vendors, to ultimately study the effect of prenatal immune activation on neurodevelopment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, College of Medicine, University of Oklahoma.
- Graduate Program in Neuroscience, College of Medicine, University of Oklahoma.
- Department of Cell Biology, College of Medicine, University of Oklahoma; Graduate Program in Neuroscience, College of Medicine, University of Oklahoma; Lindsay-Hayes@ou.edu.
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Camfield, S., Gaona-Gamboa, A., Hibbs, C. L., & Hayes, L. N. (2026). Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment. Journal of Visualized Experiments. https://doi.org/10.3791/70352
Vancouver
Camfield S, Gaona-Gamboa A, Hibbs CL, Hayes LN. Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment. Journal of Visualized Experiments. 2026. doi:10.3791/70352
BibTeX
@article{Camfield2026,
author = {Camfield, Sydney and Gaona-Gamboa, Abril and Hibbs, Clara L and Hayes, Lindsay N},
title = {Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/70352}
}
EUVIMED